SEC Form 4 · accession 0001144204-18-064669
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard James Colonno
Officer — See Remarks
Period of report
Dec 12, 2018
Accepted (ET)
Dec 14, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2018 | A | 20,000 | $0.00 | A | 110,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock issuable under a performance-based restricted stock unit (RSU) award granted on December 12, 2018 under Assembly Biosciences, Inc.'s 2018 Stock Incentive Plan pursuant to the terms of a performance-based RSU award granted to the reporting person on December 8, 2017.
Remarks
EVP & Chief Scientific Officer of Virology Operations